<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>ATHERO-B-CELL</title>
<meta name="keywords" content="biopharmaceutical, biopharmaceuticals immunogenicity, anti-drug antibody, hypersensitivity, immunotoxicology, immunization, immunogenicity of biologics, neutralizing antibody, predictive immunogenicity, ada, nab" />
<meta name="description" content="ATHERO-B-CELL: Targeting and exploiting B cell functions for treatment in cardiovascular diseases" />
<link href="css/default.css" rel="stylesheet" type="text/css" media="all" />
<script type="text/javascript" src="scripts/jquery-1.7.1.min.js"></script>
<script type="text/javascript" src="scripts/jquery.dropotron-1.0.js"></script>
<script type="text/javascript" src="css/init.js"></script>
<!--[if IE 6]>
<link href="default_ie6.css" rel="stylesheet" type="text/css" />
<![endif]-->
</head>
<body>
<div id="wrapper">
  <div id="content-wrapper" class="container">
    <div id="header">
      <div id="logo"><img src="images/logo.png" width="240" height="68" alt="ATHERO-B-CELL logo" /></div>
      <div id="header-text">
        <p><span class="athero-text">Targeting and exploiting B cell</span> <span class="athero-text">functions for treatment in</span><br />
          <span class="cell-text">cardiovascular diseases</span></p>
      </div>
      <div id="header-more"><img src="images/fp7.png" width="56" height="40" alt="Europe" /><img src="images/eu-flag.png" width="59" height="40" alt="Europe" /><br />
      </div>
    </div>
    <div id="menu-wrapper">
      <ul id="menu">
        <li><a href="index.html" accesskey="1"><span>Home</span></a></li>
        <li class="arrow"><span>Project</span>
          <ul>
            <li class="first"><a href="index.html" accesskey="2">Project summary</a></li>
            <li><a href="focus.html" accesskey="3">Project focus</a></li>
            <li class="last"><a href="organization.html" accesskey="4">Project organization</a></li>
          </ul>
        </li>
        <li><a href="objectives.html" accesskey="5"><span>Objectives</span></a></li>
        <li class="arrow"><span>Participants</span>
          <ul>
            <li class="first"><a href="participants.html" accesskey="6"><span>Participants</span></a></li>
            <li class="last"><a href="http://www.altaweb.it/atherobcell/login.asp" accesskey="7">Reserved area</a></li>
          </ul>
        </li>
        <li><a href="#" accesskey="8" onclick="javascript: alert('No document yet available.');"><span>Press release</span></a></li>
        <li><a href="#contact" accesskey="9"><span>Contacts</span></a></li>
        <li><a href="#" accesskey="10" onclick="javascript: alert('No link yet available.');"><span>Links</span></a></li>
        <li><a href="publications.html" accesskey="11"><span>Publications</span></a></li>
      </ul>
    </div>
    <div id="page">
      <div id="content" style="height:950px;">
        <h2 class="title">Athero-B-Cell project</h2>
        <div class="image-style4 image-style4a"><a href="#"><img src="images/picture_sample_01.jpg" width="202" height="138" alt="lab" /><span></span></a></div>
        <p>Cardiovascular  disease (CVD) causes nearly half of all deaths in Europe (48%), costing a  dramatic €196 billion a year. Despite the reduction in mortality that has been  achieved over the past decades, 70% of cardiovascular (CV) events cannot be  prevented with the treatment of known risk factors. Aggressive glucose  metabolism control in Type 2 Diabetes did not automatically result in CVD  prevention and lipid-lowering agents beyond statins have  not yet delivered the expected reduction in CV events highlighting a <strong>complex relationship between inflammation  and hyperlipidaemia</strong>.</p>
        <p>The  treatment of risk factors, albeit beneficial, has reached its full potential in  CVD and new treatments should be targeted to novel disease factors.</p>
        <p>Inflammation  is the important component of the pathogenesis of CVD that is not yet  therapeutically targeted.</p>
        <p><strong>B cells are a classic example of the contrasting  role of immune cell subsets in CVD.</strong></p>
        <p>Recent  studies demonstrated that <strong>B cells carry  out both pro- and anti-atherogenic functions and that these dual roles are  executed by different B cell subsets in CVD. </strong> Thus, as  in many other immune disorders, <strong>B cells  contribute to both CVD pathogenesis as well as to protection from CVD</strong>.</p>
        <p>The  limited knowledge of B cell function in atherosclerosis is hampering the  discovery of therapeutic opportunities in CVD and current therapies targeting B  cells are limited to antibodies for B cell depletion that do not discriminate  the B cell subsets and are associated with risks of immunosuppression.</p>
        <p><strong>The outstanding question is which B cell subsets  confer protection versus pathogenicity and which mechanisms do B cell subtypes  use to do this.</strong></p>
        <p>Harnessing protective or abating  unwanted B cell responses has the potential to shed light on the pathogenesis  of CVD, increase  our knowledge of pathogenic versus protective B cell responses in CVD and thus  permit the identification and validation of unexplored therapeutic targets for the prevention and treatment of atherosclerosis. </p>
        <p><a href="focus.html" class="link-style1">Project focus</a></p>
      </div>
      <div id="sidebar" style="height:950px;">
        <div id="box1">
          <h2 class="title">Recent news</h2>
          <marquee behavior="slide" direction="up" height="340" scrollamount="10">
          <ul class="style3">
            <li><span><a name"news_1">Sep</a></span><strong>Athero-B-Cell Annual meeting</strong><br />
              Siena, 21-24th September 2014<br />
              <br />
              <table border="0" cellspacing="0" cellpadding="0">
                <tr>
                  <td width="30" height="30"><img src="images/blue_arrow.png" width="16" height="13" alt="archive" /></td>
                  <td><a href="http://www.altaweb.it/galleries/abf2014/login.php" target="_blank">Open the web gallery</a></td>
                </tr>
                <tr>
                  <td width="30" height="30"><a href="documents/Agenda_Annual_Meeting_2014.pdf" title="download pdf file" target="_blank"><img src="images/pdf.png" width="16" height="16" alt="pdf"/></a></td>
                  <td><a href="documents/Agenda_Annual_Meeting_2014.pdf" target="_blank">Annual Meeting 2014 - Agenda</a></td>
                </tr>
                <tr>
                  <td width="30" height="30"><a href="documents/Agenda_Joint_Meeting_2014.pdf" title="download pdf file" target="_blank"><img src="images/pdf.png" width="16" height="16" alt="pdf"/></a></td>
                  <td><a href="documents/Agenda_Joint_Meeting_2014.pdf" target="_blank">Joint Meeting 2014 - Agenda</a></td>
                </tr>
              </table>
            </li>
            <li><span><a name"news_2">Jan</a></span><strong>Athero-B-Cell website online</strong><br />
              February 26, 2014</li>
          </ul>
          <br />
          <table border="0" cellspacing="0" cellpadding="0">
            <tr>
              <td width="30"><img src="images/blue_arrow.png" width="16" height="13" alt="archive" /></td>
              <td><a href="#">News archive</a></td>
            </tr>
          </table>
          <br />
          <br />
          <table border="0" cellspacing="0" cellpadding="0">
            <tr>
              <td width="30"><img src="images/blue_arrow.png" width="16" height="13" alt="archive" /></td>
              <td><a href="http://www.altaweb.it/atherobcell/login.asp" target="_blank">Reserved area</a></td>
            </tr>
          </table>
          </marquee>
          <br />
          <br />
          <br />
        </div>
        <div>
          <h2 class="title">Project details</h2>
          <p><strong>Acronym</strong>: Athero-B-Cell<br />
            <strong>EC Contribution</strong>: € 5.892.178<br />
            <strong>Duration</strong>: 60 months<br />
            <strong>Starting date</strong>: 01/09/2013<br />
            <strong>Instrument</strong>: Collaborative project - small or<br />
            medium-scale focused research project<br />
            <br />
            <a name="contact"></a>
            <strong>Project coordinator</strong>:<br />
            The Chancellor, Master and Scholars of University of Oxford  Prof. <a href="mailto:claudia.monaco@kennedy.ox.ac.uk" target="_blank">Claudia Monaco<br />
            </a>Kennedy Institute of Rheumatology<br />
            Roosevelt Drive, Headington, Oxford, OX3 7FY, UK.<br />
          </p>
          <p style="text-align: justify; padding-bottom:15px;">This project is supported through Coordination Theme 1 (Health) of the European Community's FP7.  Grant agreement number HEALTH-F2-2013-602114<br />
            <br />
            <span style="font-size: 10px">Last update: 15/10/2015</span><br />
          </p>
        </div>
      </div>
    </div>
  </div>
</div>
<div id="footer">
  <p>&copy; 2014 Athero-B-Cell - all rights reserved | powered by <a href="http://www.altaweb.eu" target="_blank">ALTA</a></p>
</div>
</body>
</html>
